Detalhe da pesquisa
1.
Evolving standards of care and new challenges in the management of HER2-positive breast cancer.
CA Cancer J Clin
; 70(5): 355-374, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32813307
2.
A Phase I Study of a Combination of Liposomal Irinotecan and Veliparib in Solid Tumors.
Oncologist
; 28(5): 460-e298, 2023 05 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37010988
3.
Clinical management of metastatic hormone receptor-positive, HER2-negative breast cancer (MBC) after CDK 4/6 inhibitors: a retrospective single-institution study.
Breast Cancer Res Treat
; 196(1): 229-237, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36045271
4.
Randomized Phase II Trial of Capecitabine and Lapatinib with or without IMC-A12 (Cituxumumab) in Patients with HER2-Positive Advanced Breast Cancer Previously Treated with Trastuzumab and Chemotherapy: NCCTG N0733 (Alliance).
Breast Cancer Res Treat
; 188(2): 477-487, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33852121
5.
Alliance A011801 (compassHER2 RD): postneoadjuvant T-DM1 + tucatinib/placebo in patients with residual HER2-positive invasive breast cancer.
Future Oncol
; 17(34): 4665-4676, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34636255
6.
Clinico-pathologic features, treatment and outcomes of breast cancer during pregnancy or the post-partum period.
Breast Cancer Res Treat
; 180(3): 695-706, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32162192
7.
Ten-Year Trends in Antiemetic Prescribing in Patients Receiving Highly Emetogenic Chemotherapy.
J Natl Compr Canc Netw
; 16(3): 294-299, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29523668
8.
Where Do We Stand on the Integration of PARP Inhibitors for the Treatment of Breast Cancer?
Curr Oncol Rep
; 20(8): 63, 2018 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29884921
9.
Pharmacodynamic markers and clinical results from the phase 2 study of the SMAC mimetic birinapant in women with relapsed platinum-resistant or -refractory epithelial ovarian cancer.
Cancer
; 122(4): 588-597, 2016 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26566079
10.
The TRAIL receptor agonist drozitumab targets basal B triple-negative breast cancer cells that express vimentin and Axl.
Breast Cancer Res Treat
; 155(2): 235-51, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26759246
11.
Pertuzumab and its accelerated approval: evolving treatment paradigms and new challenges in the management of HER2-positive breast cancer.
Oncology (Williston Park)
; 28(3): 186-94, 196, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24855725
12.
Standard-of-Care Treatment for HER2+ Metastatic Breast Cancer and Emerging Therapeutic Options.
Breast Cancer (Auckl)
; 18: 11782234241234418, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38410761
13.
Sexual Dysfunction in Patients With Metastatic Breast Cancer.
Clin Breast Cancer
; 24(1): 72-78.e4, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37867114
14.
OmicsFootPrint: a framework to integrate and interpret multi-omics data using circular images and deep neural networks.
bioRxiv
; 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38585820
15.
Anastrozole dose escalation for optimal estrogen suppression in postmenopausal early-stage breast cancer: A prospective trial.
Clin Cancer Res
; 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38752717
16.
Evaluation of Alisertib Alone or Combined With Fulvestrant in Patients With Endocrine-Resistant Advanced Breast Cancer: The Phase 2 TBCRC041 Randomized Clinical Trial.
JAMA Oncol
; 9(6): 815-824, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36892847
17.
Standardized Definitions for Efficacy End Points in Neoadjuvant Breast Cancer Clinical Trials: NeoSTEEP.
J Clin Oncol
; 41(27): 4433-4442, 2023 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37433103
18.
Slow Uptake of an Effective Therapy: Patterns of Olanzapine Prescribing for Those Receiving Highly Emetogenic Chemotherapy.
JCO Oncol Pract
; 18(12): e1953-e1960, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36315918
19.
Targeting Prolactin Receptor (PRLR) Signaling in PRLR-Positive Breast and Prostate Cancer.
Oncologist
; 21(5): 523-6, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27107001
20.
Regional lymphadenopathy following COVID-19 vaccination: Literature review and considerations for patient management in breast cancer care.
Eur J Cancer
; 159: 38-51, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34731748